BIOGEN INC. Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased
BIOGEN INC. (BIIB) had Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased of 1.30 million shares as of 2015-09-30, per its 10-Q filed 2015-10-21.
Discontinued › Notes › Equity
us-gaap:StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased · last filed 2015-10-21
- 2015-09-30: Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased 1.30M shares.
- 2015-06-30: Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased 1.30M shares.
| Period end | Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased |
|---|---|
| 2015-09-30 | 1.30M shares 10-Q · filed 2015-10-21 |
| 2015-06-30 | 1.30M shares 10-Q · filed 2015-07-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |